跳至主要内容
临床试验/NCT04036110
NCT04036110已完成不适用

Vitamin C Supplementation Intervention for Patients With Heart Failure-A Pilot Study

University of North Carolina, Chapel Hill2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2018年8月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
2
主要终点
Serum Vitamin C Level at Baseline

研究概览

简要总结

This study is to test a low-cost, simple vitamin C supplementation intervention, that is, comparing placebo to 500 mg/day vitamin C and 1 gram/day vitamin C daily to assess feasibility and acceptability of vitamin C supplementation and effects on serum vitamin C level, health-related quality of life (HRQOL), symptom burden, oxidative stress, and cardiac function.

详细描述

This study will address feasibility from the perspective of being able to: a) to detect significant differences in the serum vitamin C level after supplementation (3 months) between the intervention groups and the control group, b) to detect significant differences in health related quality of life (HRQOL), symptom burden, oxidative stress, and cardiac function after vitamin C supplementation (3 months) between the intervention groups and the control group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patents recruited will have a diagnosis of chronic HF, either preserved or reduced ejection fraction. The diagnosis and etiology of chronic HF will be confirmed by a HF cardiologist using established criteria.
  • Other criteria:
  • have undergone evaluation of HF and optimization of medical therapy,
  • vitamin C supplementation <500 mg/day
  • have not been referred for heart transplantation,
  • able to read and speak English,
  • >1 month from any inpatient hospitalization

排除标准

  • history of renal stones or renal disease (serum creatinine >1.5,
  • history of glucose-6-phosphate dehydrogenase deficiency (G6PD) and cognitive impairment that precludes giving informed consent or ability to follow protocol instructions

结局指标

主要结局

Serum Vitamin C Level at Baseline

时间窗: Baseline

The ELISA (enzyme-linked immunosorbent assay) used to detect and quantify Vitamin C in serum

Serum Vitamin C Level at Month 3

时间窗: Month 3

The ELISA (enzyme-linked immunosorbent assay) used to detect and quantify Vitamin C in serum

次要结局

  • Total MSAS-HF Score(Baseline and up to 3 months after enrollment)
  • Health Related Quality of Life Scores(Baseline and up to 3 months after enrollment)
  • Cardiac Function(Baseline and up to 3 months after enrollment)
  • Oxidative Stress(Baseline and up to 3 months after enrollment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验